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Abstract
Background: The worldwide population is ageing and the proportion of elderly aged 60 and over is expected to
dramatically rise in Low and Middle Income Countries (LMIC). The epidemic of dementia will not spare those
countries, where the largest increases in numbers of people affected are estimated. Besides, dementia is still
understudied in sub-Saharan Africa (SSA) compared to other regions. This paper describes the protocol for the
‘Epidemiology of Dementia in Central Africa’ population-based study, which aims at estimating the prevalence of
dementia in two countries of Central Africa and investigating possible risk factors.
Methods/Design: A multicenter population-based study was carried out in Central African Republic and Republic
of Congo between 2011 and 2012 including both urban and rural sites in each country. Around 2000 participants
aged ≥65 years old were interviewed in total using the Community Screening Interview for Dementia (CSI-D), the
GMS-AGECAT and the CERAD’s 10-word list. Elderly with low performance to the cognitive part of the CSI-D
(COGSCORE ≤ 24.5) were then clinically assessed by neurologists and underwent further psychometrical tests.
DSM-IV and NINCDS-ADRDA criteria were required for dementia and Alzheimer’s disease (AD) diagnoses respectively.
The algorithmic 10/66 dementia diagnosis was also determined. Petersen’s criteria were required for the diagnosis of
Mild Cognitive Impairment. Sociodemographic, and environmental factors including vascular, nutritional, biological,
psychosocial and lifestyle factors were collected in each setting in order to investigate factors associated with dementia.
Blood sampling was realized to investigate genetic variations that could modify the risk of dementia.
Discussion: For now, no large epidemiological study has been undertaken to compare the prevalence of dementia in
both rural and urban areas within SSA countries. This programme will provide further evidence regarding the
prevalence of dementia in SSA, and also the possible rural/urban disparities existing with associated factors.
Furthermore, the genetics of AD in those populations will be addressed.
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Background
Due to an increase of life expectancy, the worldwide popu-
lation is ageing. The number of people and relative propor-
tion aged 60 years and over is increasing. However, this
demographic transition is faster in low and middle-income
countries (LMIC) than it was during the last century in
high-income countries (HIC), and the proportion of elderly
aged 60 and over is expected to rise from 8% in 2000 to
20% in 2050 in less developed regions (World Population
Prospects 2003). The burden of non-communicable dis-
eases, including age-related diseases, is increasing and will
add to the existing burden of infectious diseases. The epi-
demic of dementia is going to affect considerably those
LMIC, where 57% of all people with dementia lived in
2010, rising to 71% by 2050 (Prince et al. 2013a). The lar-
gest increases in projected numbers of people with demen-
tia are those estimated for Eastern Asia and sub-Saharan
Africa (SSA) (Prince et al. 2013b).
Despite an increase in the number of studies on demen-
tia and Alzheimer’s Disease (AD) carried out in LMIC
during the last years, there is still a particular dearth in
epidemiological studies for some regions of the world,
especially Russia, Indonesia, the Middle-East and Africa
(Prince & Jackson 2009). While the 10/66 Dementia
Research Group estimated dementia prevalence and inci-
dence, studied risk factors and predictors of dementia, dis-
ability, dependence and mortality across several LMIC of
Latin America (Cuba, Dominican Republic, Puerto-Rico,
Peru, Mexico, Venezuela), India and China (Llibre Rodri-
guez et al. 2008; Jotheeswaran et al. 2010; Sousa et al. 2009;
Sousa et al. 2010; Ferri et al. 2011; Albanese et al. 2013;
Prince et al. 2012), dementia is still understudied in sub-
Saharan Africa. In the 90s in Nigeria, the Indianapolis-
Ibadan Dementia Project estimated the age-adjusted preva-
lence of dementia (according to DSM-IV/ICD-10 criteria)
at 2.3% in the Yorubas aged 65 and over living in Ibadan,
and the prevalence of AD at 1.4% (Hendrie et al. 1995).
These low prevalences of dementia were first confirmed by
two population-based studies in Benin, where the age-
standardized prevalences of dementia were estimated at
3.3% in a rural area (Guerchet et al. 2009) and 2.9% in
Cotonou, the economic capital (Paraïso et al. 2011). Never-
theless, other recent studies from Central and East Africa
showed a different picture, reporting age-standardized pre-
valences of 7.6% and 5.4% respectively in capitals of
Central African Republic and Republic of Congo (Guerchet
et al. 2010) while the age-standardized prevalence in rural
Tanzania was 6.4% (Longdon et al. 2013). In contrast with
Latin American countries, it is less clear whether urban liv-
ing is associated with dementia in other regions of the
world (Kalaria et al. 2008). For now, no multicentre study
using the same protocol has been undertaken to compare
the prevalence of dementia in both rural and urban areas
within SSA countries.
Determinants of dementia risk, modifiable or not, are
suggested to impact across the life course similar to other
chronic conditions of late life (Prince et al. 2014). Ageing
is the main risk factor for dementia, with a prevalence
doubling with every 5.5 to 6.7 years increment in age over
the age of 60 (Prince et al. 2013a). Vascular factors are also
important contributors to dementia risk (Barnes & Yaffe
2011), with evidence showing associations between de-
mentia and midlife hypertension (Qiu et al. 2005; Kennelly
et al. 2009), diabetes (Biessels et al. 2006; Profenno et al.
2010), midlife obesity (Barnes & Yaffe 2011), elevated mid-
life cholesterol (Solomon et al. 2009), physical inactivity
(Hamer & Chida 2009) and smoking (Anstey et al. 2007;
Peters et al. 2008). Among all psychosocial factors, history
of depression (Jorm 2001; Ownby et al. 2006) is a robust
possible risk factor. Many other aspects are also investi-
gated (diet, female reproductive health, environmental fac-
tors, cognitive activity or traumatic brain injury) often
showing conflicting results.
However, once again, the evidence is mostly issued from
studies carried out in HIC or any other continent than
SSA, and data for this region are scarce. For now, common
factors like age or female sex have been associated with
cognitive impairment or dementia in Nigeria, Benin and
Central Africa (Guerchet et al. 2010; Ochayi & Thacher
2006; Hall et al. 1998; Ogunniyi et al. 2000; Ogunniyi et al.
2006; Gureje et al. 2006), mainly in cross-sectional studies.
A low Body-Mass Index (<18.5 kg/m2), indicating under-
nutrition, was also retrieved in both Nigeria and Central
Africa (Ochayi & Thacher 2006; Guerchet et al. 2012),
while other associations were reported in Nigeria only (life-
time history of alcohol use, living with others) (Ogunniyi
et al. 2000; Gureje et al. 2006) or Central Africa only
(hypertension, depressive symptoms, death of a parent be-
fore age of 16, recent moving) (Guerchet et al. 2012). In
the same populations, education was not significantly as-
sociated with dementia in multivariate analysis (Ochayi &
Thacher 2006; Hall et al. 1998; Ogunniyi et al. 2000;
Ogunniyi et al. 2006; Gureje et al. 2006). However, a small
proportion of the participants had formal education be-
yond primary school in these studies.
The attributable genetic risk in common forms of
dementia and particularly AD, is exceptionally high
(~80%) amongst common multifactorial ageing diseases,
e.g. well above those reported for type II diabetes
(~40%) or Parkinson's disease (~30%) (Gatz et al. 2006).
Even if this evaluation has been done in populations
from Caucasian origins, it is reasonable to assume that
it is the same for populations from other origins such as
subjects of African ancestry. However, such a postulate
raises the following question: are the recognized genetic
risk factors in Caucasians (e.g, monogenic mutations,
APOE and GWAS defined-genes) similar of the ones
involved in Africans (European Alzheimer's Disease
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Initiative (EADI) et al. 2013; Cruchaga et al. 2014; Guerreiro
et al. 2013)?
Most of the information available are indirect and con-
cern subjects of African-American ancestry for whom
APOE and several GWAS-defined genes have been associ-
ated with AD risk (Reitz et al. 2013; Logue et al. 2011).
Very few studies were able to address AD genetics in
Africans. To date, a PS1 mutation has been reported in a
large family of indigenous Southern Africans (Heckmann
et al. 2004) and the ε4/ε4 genotype has been associated
with an increase in AD risk in the Nigerian Yoruba popu-
lation (Hendrie et al. 2014).
Aims of the EPIDEMCA programme
1. To estimate and compare the prevalence of dementia
and related syndromes in urban and rural areas in
Central Africa (Central African Republic and Republic
of Congo), and to study the neuropsychological
profiles of demented and non-demented subjects,
2. To investigate factors associated with dementia and
cognitive disorders: sociodemographic, environmental
factors including vascular, nutritional, lifestyle and
biological factors,
3. To determine if genetic variations can modify the risk
of dementia in African populations,
4. To create a biobank from native elderly Africans in
order to carry out further biological, genotypic and
phenotypic researches in the future.
Methods/Design
Study design
Cross-sectional two-phase surveys were conducted
between November 2011 and December 2012 in a
sample of 2002 people aged 65 years old and over; with
a sample size around 500 participants in each of the 4
settings (Table 1), with an identical data collection
protocol in the 4 settings for the sake of comparability
(dementia screening and diagnosis, demographics,
physical assessment, and risk factor questionnaire).
Frozen blood plasma and DNA will be available from
each setting and will be saved for further biochemical
and genetic analyses.
Settings
Four settings were investigated in two LMIC: the Central
African Republic (CAR) and the Republic of Congo (ROC)
(Figure 1). In each country, one urban area (respectively
Bangui and Brazzaville) and one rural area (Nola and
Gamboma) were included. Urban areas were both capitals,
and the biggest cities, of those countries. Rural areas were
defined by a lower population density and traditional
agrarian lifestyle.
The Central African Republic is a landlocked low-
income country (The World Bank, Data, Central African
Republic). According to the last national census (Recense-
ment Général de la Population et de l’Habitat 2003), its
population includes 2.6% aged 65 years and over, and the
life expectancy at birth is 48.3 years (The World Bank,
Data, Central African Republic). Bangui is located on the
side of Oubangui river, in the South of the country, and its
population is estimated at 622 771 inhabitants. The city
is divided in 8 main administrative subdivisions over
67.0 square-kilometres. Nola, the rural site located in
the Sangha-Mbaéré prefecture, is situated 422 kilome-
ters south-west from Bangui, with a total population of
7419 inhabitants. Smaller villages within the 10 kilo-
metres radius from Nola were also included into the
rural CAR setting.
The Republic of Congo is a lower-middle income coun-
try (The World Bank, Data, Republic of Congo). Its popu-
lation aged 65 years old was estimated at 3.2% of the total
population in the last national census (2007) (Recense-
ment Général de la Population et de l’Habitat 2007 2010).
Life expectancy at birth is 51.1 years (The World Bank,
Data, Republic of Congo). Brazzaville is located on the side
of the Congo River, in the south of the country, and its
population is estimated at 1 373 382 inhabitants. The
city is divided in 9 main administrative subdivisions, over
263.9 square-kilometers. Gamboma, a rural setting in the
Plateau Region, is situated 314 kilometres north from
Brazzaville, with a total population of 18 514 inhabitants.
Albeit neighboring countries, CAR and ROC show
some disparities (Table 2) (United Nations Development
Program 2013). The main industries of ROC are linked
to oil and wood; other industries are poorly developed
and of only local importance. Forestry and mining are
the only developed industries in CAR; there are essen-
tially no others. Brazzaville is overall more urban, with
Table 1 EPIDEMCA population-based survey, Central Africa, 2011-2012
Country Study area Sample Interviews
completed
Response rate% Blood sample Lost-of follow-up Start/End
Central African Rep. Nola (rural) 501 473 94.41 393 66 Nov. 2011/Feb. 2012
Bangui (urban) 514 500 97.28 441 48 Jan. 2012/March 2012
Rep. of Congo Gamboma (rural) 561 529 94.30 836 93 Aug. 2012/Dec. 2012
Brazzaville (urban) 537 500 93.11 409 17 Sept. 2012/Nov. 2012
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increased development of a Western way of life and higher
socio-economic conditions as compared to Bangui.
Sampling and sample size
Sampling methods differed between urban and rural areas.
To be representative of Bangui and Brazzaville inhabitants,
a random sampling proportional to the size of each main
subdivision of the city was realized in urban sites. For each
main subdivision, a district has been randomly chosen.
Then, the procedure was the same in each district: door-
to-door survey was conducted in a random direction, start-
ing from the district chief ’s house, until the number of
participants allocated to each subdivision was reached. If
the number of participants was not reached in the first
district, the procedure was applied in another random dis-
trict belonging to the same subdivision.
In rural areas, a door-to-door approach was preferred
due to logistical and financial constraints. Each district
constituting the area was investigated. In case of absence
of inhabitants during the day of screening, houses were
revisited at least twice to check the presence of old people.
For both types of settings, every house visited was
marked by the investigators (name of the study, number
of the house, participant and investigator) with chalk,
just above the door, ensuring exhaustive coverage, even
in the absence of addresses.
The only exclusion criteria were refusal or the pres-
ence of severe comorbidities precluding the interview
and/or cognitive testing in absence of an informant.
Precision calculations indicated that a sample of 456
people in each site would allow estimation of an expected
dementia prevalence of 5% with a precision of +/- 2%
(EpiInfo 6.04, Epiconcept). We then aimed at including
about 500 elderly in each setting.
The sample of elderly included in this study was aged be-
tween 65 and 99 years (maximum 93 in Nola and Bangui,
99 in Gamboma, and 95 in Brazzaville), with a mean age of
73.3 ± 6.7 years (respectively 72.8 ± 6.5, 72.6 ± 6.4, 74.0 ± 6.9
and 73.6 ± 6.7 years in each setting). Women represented
the highest proportion of our population, with a global sex-
ratio (M/F) of 0.63, ranging from 0.54 to 0.69 in CAR and
of 0.64 for both areas in ROC. A small proportion (5.4%) of
the participants reported to live alone (from 1.6% in Bangui
to 6.8% in Nola), and more than two-third (68.8%) did not
receive any formal education (75.4% in Nola and 63.3% in
Bangui, 82.0% in Gamboma, and 54.1% in Brazzaville).
Preparation
Each coordinator collaborated on neuroepidemiological
studies for several years and has already been involved
in previous studies on dementia (Guerchet et al. 2010;
Mbelesso et al. 2012). They participated to design the
study protocol before applications for funding. Conference
calls and live meetings were held regularly during the year
prior to the study.
In each country, Universities and Ministries of Health,
Research and Public Health were informed and supported
the study. Prefectures, town halls and sanitary districts re-
ceived information about the aims and schedule of the
study. District chiefs were visited prior to start the screen-
ing in order to increase awareness and population accept-
ance. Messages were broadcasted on a local radio in Nola
(CAR) and disseminated by town criers in Gamboma
(ROC) and Bangui (CAR).
Figure 1 Localisation of the Republic of Central Africa and Republic of Congo, and rural and urban settings within each country.
Table 2 Characteristics of the Central African Republic
and the Republic of Congo
RCA ROC
Surface (km2) 623 000 342 000
Number of inhabitants 3 895 139 3 697 490
Capital Bangui Brazzaville
Density population (inhab/km2) 7.2 12.4
Rural population 62% 35%
Human development indice 0.352 0.534
Human development indice rank 2013 (/186) 180 142
Gross domestic product per capita (PPP US$) 722 2 934
Life expectancy at birth (years) 49.1 57.8
Poverty headcount at national poverty line 62% 47%
GDP: Gross domestic product.
http://www.who.int/countries/en/ and http://hdr.undp.org/en/statistics/.
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Interviews and measures
Assessments were translated into the relevant local lan-
guages: Sango in CAR, Lingala, Kituba and Lari in ROC.
These translations were done from French to local lan-
guages, then from local languages to French in order to
observe translation consistency.
The first phase was conducted in the participant or
their relative’s homes, including the following assess-
ment: cognitive and physical assessment, demographics
and risk factor questionnaire. After the identification of
participants at risk of dementia through the question-
naires, the second phase was conducted few weeks later
(between 3 and 14), at the closest hospital or community
health centre, by neurologists in presence of selected
participants and an informant, most of the time one of
their relatives.
1. Epidemiological assessements
The participants, or informant in case of communication
difficulties due to dementia, poor physical condition,
extreme fatigue, hearing or oral problems, have provided
this information.
Sociodemographic status
Age was ascertained by official documents (national iden-
tity cards, passports, birth certificates). In case of absence
of these documents or discrepancy between documents
and participants reports, age was estimated using two his-
torical landmarks in each country or through a local event
calendar, using a validated method (Ogunniyi & Osuntokun
1993; Paraïso et al. 2010). Age was ascertained from an in-
formant if none of those methods was successful.
Marital status, living circumstances, education (no for-
mal education, primary, secondary or higher education,
certificate of primary school validated or not), literacy, and
ethnic group were collected. Further information about
rural or urban residence across life course, current occu-
pation, and past occupation was sought.
Participation to religious ceremonies or other social
activities (playing games and meeting with friends) was
recorded, as well as their participation to children’s edu-
cation. Indications on happiness of each participant were
collected using one section of the Center for Epidemio-
logic Studies Depression Scale (Radloff 1977).
Lifestyle and cardiovascular risk factors
Tobacco and alcohol use were investigated through self-
report. Mode of consumption (smoked, quid, snuff to-
bacco), volume and frequency, and lifetime smoking
(never, ever or current smokers) were recorded. Alcohol
consumption was described (alcohol type, frequency and
units of alcohol per week).
Diet was investigated. A food frequency questionnaire
asked if people ate their fill or not, whether the food was
all consumed, and if there were any dietary restrictions.
The number of meals per day was recorded, as were the
reasons for people eating fewer than three. The frequency
of consumption over the past 3 days was recorded for dairy
products, fruits, vegetables, starches, legumes, oil seeds,
meats or fishes, eggs, and sweet foods.
Current physical activity was estimated using a thresh-
old of at least 150 minutes of walking or cycling in the
past week (World Health Organization 1984a).
2. Clinical assessments
Health status
Self-reported comorbidities were investigated through the
Charlson’s weighted comorbidity index (Charlson et al.
1987). Self-reported diagnosis concerned stroke, diabetes,
hypertension, and treatments for these conditions, using
the following questions: ‘Have you ever been told that you
had…? Were you started on treatment? Are you still on
treatment?’. Familial history of dementia and previous
head injury were also investigated.
A full direct physical assessment was realized includ-
ing the following measures.
– Height (expressed in centimetres, measured by a
carpenter meter along a flat surface), weight (expressed
in kilograms measured on SECA® mechanical scales).
Height was estimated using the Chumlea formula
based on the heel-knee distance if the height was
impossible to measure (participant unable to stand
upright) (Chumlea et al. 1998). Body Mass Index
(BMI) was calculated by dividing weight in kilograms
by height in metres squared (kg/m2) and categorized
according to the WHO recommendations: BMI <18.50
is considered underweight, BMI between 18.50 and
24.99 is considered normal range, a BMI between 25.00
and 29.99 overweight, and a BMI ≥ 30.0 defines obesity
(World Health Organization 1984b).
– Waist circumference (measured in cm, midway between
the lower rib margin and iliac crest) and hip
circumference (measured in cm, at level of the highest
circumference by including buttock). The waist-to-hip
ratio (WHR) was then calculated by dividing waist
circumference by hip circumference. The presence of
abdominal obesity was determined following the
recommended waist circumference thresholds for
abdominal obesity in sub-Saharan Africans (Alberti
et al. 2009).
– Mid-upper arm circumference (MUAC, measured at
the nearest mm, on the right arm, midway between
acromion and olecranon), triceps skinfold thickness
(TST, measured on right arm three times to the
nearest 0.2 mm according to Lohman standard
procedures (Lohman et al. 1988) with an Harpenden
Guerchet et al. SpringerPlus 2014, 3:338 Page 5 of 12
http://www.springerplus.com/content/3/1/338
calliper). Arm muscle circumference (AMC, cm),
representing muscle mass, will be calculated using
the following formula: AMC =MUAC (cm) - (0.314
*TST (mm)) (Gurney & Jelliffe 1973).
– Leg length (measured from the iliac crest down to the
lateral malleolus on the right leg, in centimetres)
and skull circumference (measured just above the
participant’s eyebrows and round to the occipital
pole at the back of the skull, in centimetres).
– Pulse rate, systolic and diastolic resting blood pressure
(two measures for each arm) were recorded.
Hypertension was defined in case of self-reported
ongoing treatment and/or when systolic blood
pressure (SBP) at rest was ≥140 mmHg and/or dia-
stolic blood pressure (DBP) was ≥90 mmHg (World
Health Organisation 2013).
– Ankle-Brachial Index (ABI): Doppler ultrasound (Super
Dopplex II, Huntleigh Technology PLC, Luton, UK)
was used to measure SBP in the posterior tibial and
dorsal pedis arteries bilaterally. The measurement
protocol and ABI calculation were performed
according to the American Heart Association
guidelines (Aboyans et al. 2012). Peripheral artery
disease will be defined as an ABI ≤0.90.
– Capillary blood glucose level (Accu-Chek® Performa,
Roche). Diabetes was defined according to self-reported
diabetes or in case of elevated blood glucose level,
above 126 mg/dL if the fasting period > 2 hours or
above 200 mg/dL in non-fasting participants (World
Health Organization 2006).
Frailty
The SOF index (Study of Osteoporotic Fracture) was cal-
culated based upon three components: self-reported unin-
tentional weight loss, inability to rise from a chair five
times without the use of arms, and self-reported low en-
ergy level. Frailty status was defined as robust (0 compo-
nents), prefrail (previously referred to as “intermediate”, 1
component), and frail (≥2 components) (Kiely et al. 2009).
The walking speed (over a 4.5 metre distance) was also
recorded.
3. Psychological assessments
The Community Screening Interview for Dementia
(CSI-D) was performed with each participant (Hall
et al. 1993), allowing the calculation of the
COGSCORE (incorporating the CERAD animal
naming verbal fluency) and the RELSCORE
(providing evidence of cognitive and functional
decline reported by an informant). As previous
studies (Guerchet et al. 2009; Paraïso et al. 2011;
Guerchet et al. 2010) highlighted the difficulty to
perform CSI-D praxies items for subjects who have
no formal education, the last items (requiring
writing skills) were replaced by two-items from the
Stick Design Test (Baiyewu et al. 2005).
A structured clinical mental state interview, the
Geriatric Mental State version B3 (GMS-AGECAT)
(Copeland et al. 1986) identifying depression, anxiety
and psychosis, and the modified CERAD 10 word
list learning task with delayed recall (Ganguli et al.
1996) were added to this cognitive battery.
Diagnoses of MCI, Dementia, Alzheimer’s disease
All subjects who obtained a poor performance to the
CSI-D (COGSCORE ≤ 24.5, sensitivity = 93% and speci-
ficity = 82% in the EDAC study, personal data) were
convened to a further clinical assessment with a neur-
ologist (second phase) (see Figure 2). Neurological as-
sessments were completed by additional cognitive tests:
the Free and Cued Selective Reminding Test (Grober et al.
1988) (oral version with image), Zazzo’s cancellation task
(Zazzo 1974) and Isaac’s Set Test of verbal fluency
(Isaacs & Kennie 1973). The questionnaire was adminis-
tered during a face-to-face interview of the subject and
of an informant.
Careful description of daily living activities particularly
leisure, other social activities, Instrumental Activities of
Daily Living with the same level of precision as the Lawton
scale (Lawton & Brody 1969) but adapted to the African
context, occupational activities, social habits, and orien-
tation skills were investigated in order to evaluate the
dependence.
Diagnosis of dementia was made according to the
DSM-IV criteria (American Psychiatric Association 2003)
and according to the clinical criteria proposed by the
NINCDS-ADRDA (National Institute of Neurological and
Communicative Disorders and Stroke and the Alzheimer’s
Disease and Related Disorders Association) for AD
(McKhann et al. 1984). Diagnosis for other types of de-
mentia (especially vascular dementia) was based on history
of stroke and other clinical arguments. Petersen’s criteria
were used for Mild Cognitive Impairment (Petersen 2004).
Experienced neurologists reviewed all medical records and
performances to tests, and consensus on the diagnosis was
obtained. Subjective memory complaints were recorded
with the ‘Questionnaire de Plainte Cognitive’ (Thomas
Antérion et al. 2003) and the severity of dementia evalu-
ated by the Clinical Dementia Rating Scale (Morris 1993).
Behavioural and Psychological Symptoms of Dementia
were investigated through the NeuroPsychiatric Inventory
(NPI) (Cummings et al. 1994).
The 10/66 dementia diagnosis was determined later,
using the 10/66 validated dementia computerized algo-
rithms based upon the CSI-D, the CERAD 10 word list
learning and animal naming tests, and the Geriatric
Mental State B3 (Prince et al. 2008).
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Stressful life events
Stressful psychosocial factors were investigated for three
different life periods as already described by Persson &
Skookg (Persson & Skoog 1996): before 16, between 16
and 64, and after 65 years old. Eighteen life events were
looked for: 5 before the age of 16 (death of a parent, di-
vorce of parents, growing up with one parent, different
guardians, extreme poverty), 5 between 16 and 64 years
old (death of a spouse, death of a child, serious illness in
a child, shift or piece work and arduous manual work),
and 8 from 65 years of age (death of spouse, physical ill-
ness in spouse, mental illness in spouse, death of a child,
serious illness in a child, death of siblings or friends,
change of residence and financial status deterioration).
Dependent personality disorders
The presence of dependent personality disorders (DPD,
DSM-IV Axis II) was screened through the dependent
personality domain of the Personality Diagnostic Ques-
tionnaire –4 plus (PDQ4+) (Hyler 1994). Dependent per-
sonality disorders were present if at least five items out
of 8 were responded positively.
4. Biological assessments
Blood sample protocol
Blood samples were sought from all participants. After the
interview and the physical assessment, dedicated nurses
performed a phlebotomy for consenting participants. Blood
was drawn on two 10 ml polypropylene EDTA tubes for
DNA extraction and biological analyses. Samples were
registered in a database, centrifuged and aliquoted within
few hours (to avoid degradation due to high tempera-
tures), and then transferred to a laboratory to be frozen
at -20°C or -80°C. Plasma and buffy-coat aliquots were
stored at the Pasteur Institute of Bangui and the National
Laboratory of Public Health in Brazzaville before dry-ice
shipping to the University of Limoges, where the biobank is
located.
Biological assessments
Total cholesterol and C - reactive protein (CRP) dosages
were performed on plasma aliquots in the Biochemistry
department of the Limoges University Hospital using
standard procedures (on Cobas automaton). Hypercholes-
terolemia was then defined when above 5.3 mmol/L and a
high CRP level, an inflammatory marker, was considered
when above 5 mg/L.
Genotyping
DNA was extracted in the Inserm U744 unit (Pasteur
Institute, Lille, France) using standard procedures. Asso-
ciation of APOE and GWAS-defined genes with AD risk
will be assessed in order to evaluate whether genetic risk
factors in Caucasian are also involve in individuals of
African ancestry. We acknowledge that the statistical
power of our study might be restricted according to the
magnitude and level of association of most of these
Figure 2 Flow chart of the EPIDEMCA study, Central Africa, 2011-2012.
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genes with AD risk in Caucasian. However a recent
work indicated that variants in ABCA7 might have a
stronger impact in African-Caucasians than the one pre-
viously observed in Caucasians. Genetic analyses in our
samples might thus allow to point out genes with par-
ticularly high impact in Africans and thus suggest spe-
cific pathophysiological pathways to be targeted for drug
designs in these populations.
Resources/training/quality control
Every country had a local project coordinator (PM, BNB)
and ten interviewers, who were generally medical residents
(at least in their 6th year), students in biological curricu-
lum or nurses, from Bangui and Brazzaville Universities.
All the interviewers were trained during three weeks in
the main assessment and the physical measures included
in the protocol. Interviewers were selected according to
their performances during the training.
Groups of three interviewers were supervised on the
field by the project coordinator or an epidemiologist dur-
ing the whole duration of the study. Field interviews were
randomly supervised to control the good execution of the
different tasks, and solve any problem when occurring.
Data management
The interviewers collected data directly onto laptop
computers during the study. Questionnaires were com-
puterized using EpiData (version 3.1) software, including
conditional skips and interactive checking for data
consistency. Identical Epidata files were used in each set-
ting, ensuring facilities to data processing and merging.
The 10/66 algorithm was processed using SPSS (version
17.0, IBM SPSS Statistics). Data cleaning, and processing
of variables was done using Stata (version 10.1, Stata-
Corp, College Station, Texas, United States) and SAS
(version 9.2, SAS Institute, Cary, NC) softwares.
Datasets are stored on secured servers at Limoges
University, and declared to the ‘Commission Nationale
de l’Informatique et des Libertés’ (CNIL) according to
our national regulations on personal data.
Ethical issues
Each participant and family members were informed
about the study and consent was obtained from subject
and/or family when the former was unable to express
his/her consent. Written consent was obtained every
time when feasible. For illiterate people, the purpose of
the study was verbally explained and the consent was
obtained by thumbprint marks.
In both countries, ethical committees, supervised by
Ministry of Public Health in CAR and the CERSSA
(Comité d’Ethique de la Recherche en Sciences de Santé)
in ROC, approved the study protocol, as well as the
CPP-SOOM-IV (Comité de la Protection des Personnes
Sud-Ouest Outre-Mer) in France.
Statistical analyses
For every site, participants’ characteristics will be de-
scribed: age, sex, marital status, education level, and health
status. Continuous variables will be reported using means
and standard deviations (SD) for the normally distributed
variables otherwise medians and inter-quartile ranges
(IQR) will be reported. Categorical variables will be re-
ported using numbers and percentages. Normality of
the variables will be examined using standard test with
skewness and appropriate transformations applied if re-
quired. Chi-square, Fisher exact or Student’s t-tests will
be used to determine if statistically significant differ-
ences exist between groups, according to the nature of
the variable and numbers.
The prevalence of DSM-IV and 10/66 dementias, AD
and MCI, by gender and age in 5-years bands will be esti-
mated for each site, with their 95% confidence intervals.
We will standardize for age and sex the prevalence rates on
the Sub-Saharan population (United Nations Department
of Economic and Social Affairs Population Division) to
make comparisons of dementia according to the 10/66 and
the DSM-IV criteria between our study sites. Clinical sever-
ity for dementia cases will be described. The independent
effects of age, sex, education and ApoE genotype on de-
mentia prevalence will be provided from a Poisson regres-
sion model, separately for each site and then combined.
Multivariate regressions analyses will be used to esti-
mate risk associations between the different exposures
and cognitive status (dementia, MCI, cognitively normal),
adjusted on the relevant socio-demographic, vascular, psy-




One-phase studies may be an ideal for dementia preva-
lence studies (Prince 2000) but two-phase studies, often
preferred in low and middle-income countries, are a
more pragmatic approach to research when carrying out
a full clinical assessment of large populations is not pos-
sible due to practical and financial constraints.
Two-phase surveys are known to increase the risk of
attrition between the first and the second phase (Prince
2000), consequently increasing the risk of moving, death
or refusal from people with dementia before to establish
the diagnosis. However, previous 2-phase studies in
Benin, Central African Republic, Congo and Tanzania
(Guerchet et al. 2009; Paraïso et al. 2011; Guerchet et al.
2010; Paddick et al. 2013) showed lower attrition rates
than described by the 10/66 Dementia Research Group
(Prince 2000), reassuring us about the feasibility and the
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robustness of two-phase epidemiological surveys in SSA.
The threshold used to select participants for the second
phase and clinical assessment was furthermore defined ac-
cording to sensitivity and specificity found in previous
studies carried out in the same elderly populations. An-
other advantage of a two-stage design is to exclude from
the diagnosis of Dementia, transient delirium.
As our programme also aimed at determining the neuro-
psychological profiles of people with dementia within this
context, a more comprehensive interview with a clinician/
specialist and the inclusion of additional neuropsycho-
metrical tests (Free and Cued Selective Reminding Test,
Isaac’s Set Test of verbal fluency and Zazzo’s cancellation
task) was indicated for the second phase.
While dementia defined by the 10/66 criteria has shown
higher prevalences of dementia across the 10/66 studies,
authors suggested that the DSM-IV may consistently
underestimate the prevalence of dementia by including
only the more severe cases, especially in regions with low
awareness and less developed (Llibre Rodriguez et al.
2008). Recently, the age-standardized dementia prevalence
estimates according to those two different criteria, DSM-
IV and 10/66, were reported and compared in a rural area
of Tanzania (Paddick et al. 2013). Prevalence of dementia
was again higher when using the 10/66 criteria than the
DSM-IV. Of note education was a significant predictor of
dementia when defined by the 10/66 criteria, but not of
DSM-IV criteria. However, the authors did not conclude
whether the association between education and diagnosis
was authentic or the result of an educational bias within
the diagnostic instrument. As we included the GMS-
AGECAT and the modified-10 word list in addition to the
CSI-D in our programme, the 10/66 dementia prevalence
will be estimated, allowing further comparisons between
both DSM-IV and 10/66 dementia criteria, and the poten-
tial effects of education.
During this programme, both urban and rural areas were
investigated enabling to have a larger picture of the burden
of dementia in those countries. Sampling methods were
yet different. A sampling proportional to the size of the
main subdivision of each capital was applied in both urban
areas. Indeed in both capitals distribution of ethnic groups
differs from one subdivision to another. The definition of a
catchment area within the city would not have permitted
to recruit a sample of participants fully representative
of the Bangui and Brazzaville’s inhabitants. Furthermore,
door-to-door studies in defined catchment areas of both
cities have been carried out previously (Guerchet et al.
2010). An exhaustive sampling, by a door-to-door knock-
ing, was preferred in rural areas. This procedure was more
suitable in areas where addresses are completely inexistent,
and will allow us to tag the participants for further studies
more easily. Data collection in a geographically defined
area was also financially and logistically (i.e. blood sample
procedure) feasible. However, as distribution of ethnic
groups differs from one region to another in both coun-
tries, we are aware that the results reported for rural areas
would not necessarily be generalizable to any other rural
area within the country.
Feasibility
The feasibility of this programme is an essential issue,
and mainly raises the two following points: security in
the countries/areas where the research is carried out and
reliability of our network/collaboration.
The ROC and the CAR have known political distur-
bances and civil wars in the 90s and early 2000s. Since, the
situation is stable and secure in the ROC. Some areas were
still hold by rebels in eastern and northern CAR, but Nola
and Bangui were completely secured during the time we
were planning and carrying out the surveys there. Never-
theless, the coordinators and the teams respected all the
usual safety rules and procedures (Governments of CAR
and ROC as well as French Embassies/Diplomacies).
As already mentioned in the preparation section, the
local collaborators and the French research units have been
collaborating on previous projects on dementia before to
take on this new programme, which ensured us the quality
and strengths of this multicentre collaboration. Further-
more, the two local collaborators (BNB and PM) are asso-
ciated members of the Inserm UMR1094 (Limoges) and
have carried out several other research projects on the epi-
demiology of epilepsy or other neurological disorders.
Dissemination
Results from this programme will be disseminated at
both international and national levels. They will be com-
municated to international agencies of concern, in par-
ticular to the World Health Organization (African office,
Brazzaville) and Alzheimer Disease International (ADI,
London). These findings will be used in each country to
raise public awareness, stimulate clinical training and
practice, and influence social and health care policies.
A strategy for dissemination was established between
all the investigators during a meeting held in Limoges in
May 2013. Dissemination through peer-reviewed articles
will be prioritized. All the investigators have access to
the full anonym database. The final dataset will be ap-
proved by the coordinator of the programme and stored
securely on Limoges University network. All proposals
for publications should be addressed and approved by
the coordinator and all the investigators. Public access
to the database by external investigators will be opened
one year after the release of the final version (i.e. 01/07/
2015). Applications for use of the data should be sent to
the responsible of this programme (preux@unilim.fr or
ient@unilim.fr).
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Role of the funding source
This study was funded by a grant from the French
National Research Agency (ANR-09-MNPS-009-01).
The sponsors of the study had no role in study design,
data collection, data interpretation, or writing of the re-
port. All authors had full access to all the data in the
study, and the corresponding author had final responsi-
bility for the decision to submit for publication.
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